Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 403 followers
Latest posts
Last updated about 4 hours ago
Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
about 4 hours ago
Novartis CEO Vas Narasimhan says that Europe needs a “complete rethink” on...
Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
about 4 hours ago
Pfizer now anticipates its Vyndamax sales to remain “relatively stable” from 2028...
FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
about 6 hours ago
The FDA has released briefing documents detailing its concerns for AstraZeneca’s cancer...
FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
about 9 hours ago
The FDA has told Amgen that it is proposing to withdraw the...
With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
about 9 hours ago
After recalibrating its production strategy in the late 2010s to help meet...
Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
about 9 hours ago
Rocket Pharmaceuticals has offloaded its lucrative FDA rare pediatric disease priority review...
AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
about 10 hours ago
After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler...
Haleon scores branding goal with star-studded soccer offensive
about 10 hours ago
Haleon has kicked off a soccer-focused marketing campaign ahead of the Fifa...
Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition
about 10 hours ago
Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak...
GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio
about 12 hours ago
Ahead of the July trial, a Delaware court upheld GSK's Jemperli royalty...
Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win
1 day ago
Mundipharma and CorMedix have announced a win for their antifungal drug Rezzayo...
Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026
1 day ago
Compared with a 5.3% increase in Xtandi sales to $6 billion in...